KPBMA

Home KPBMA
A COVID-19 pandemic has activated the consignment production of vaccines developed by multinational pharmaceutical companies in South Korea, elevating the status of domestic pharmaceutical and bio companies that have exhausted efforts over the past decade to innovate quality and develop new drugs, becoming a crucial industry like automobiles and semiconductors.
Author:alopah/Date:2021-07-28/Views:252